Was FDA Nit-Picking In Criticism Of Pfizer's EAGLES Trial?
Executive Summary
When industry rep questioned whether problems with smoking cession drug trial were overestimated, FDA's rebuke was swift.
You may also be interested in...
FDA Makes Rare Call, Removes Boxed Warning From Chantix, Zyban Labels
Pfizer, GSK score as neuropsychiatric symptom risks now only appear in Warnings and Precautions section following EAGLES trial results.
Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?
FDA could use advisory committee members' comments to maintain the smoking cessation drug's boxed warning, even though they voted to remove it.
Chantix's Boxed Warning: Will A Positive Vote Justify A Negative Outcome?
FDA could use advisory committee members' comments to maintain the smoking cessation drug's boxed warning, even though they voted to remove it.